← Back to the library

BPC-157

peptide

Recovery-focused research peptide

Research status · Not FDA-approved

Not FDA-approved for any use; considered a research chemical. Compounding status shifted in 2025–2026 FDA reviews — verify. Human evidence is very limited.

BPC-157 is a synthetic peptide widely discussed for soft-tissue and gut recovery. It has not been approved for human use and lacks completed human clinical trials. Anyone considering it should discuss legality, sourcing, and safety directly with a clinician.

How it works

Proposed to support angiogenesis and tissue repair signaling (mostly animal/cell data); human mechanism not established.

Commonly discussed use cases

  • Tendon/soft-tissue recovery (discussed)
  • Gut comfort (discussed)

Supposed / potential benefits

  • Recovery claims come largely from animal studies and anecdote, not human trials

Common side effects

  • Injection-site irritation
  • Nausea/dizziness (reported)
  • Unknown long-term effects

Warnings & contraindications

  • Not FDA-approved; no completed human RCTs
  • Improvement may simply reflect smart rehab/loading
  • Unregulated products carry purity/identity risks

Typical timing considerations

No established regimen; any use should be clinician-directed. Exhaust conventional rehab first.

Administration route

Subcutaneous injection (also discussed orally, evidence weaker)

Storage

Refrigerate after reconstitution; follow instructions.

Questions to ask your clinician

  • Should I exhaust standard rehab/physical therapy first?
  • What evidence exists for my specific issue?
  • How would we judge whether it's doing anything?

Commonly tracked in Reta

Target symptom rating (daily)Rehab work doneInjection site rotationNew symptoms

Tracking fields organize user-entered, clinician-directed routines — Reta never recommends or computes doses.

Sources

Track this in Reta

Beta members get a ready-made tracker for BPC-157 — schedule, dose log, injection-site rotation, reminders, and check-ins — for organizing a clinician-directed routine. Personal tracking is available to everyone during the Public Beta.

Reta is a tracking and education tool — not a medical provider. Nothing here is a diagnosis, treatment, prescription, or dosing recommendation. Peptides and medications should only be used under the direction of a licensed clinician. Talk to a qualified clinician before starting, stopping, combining, or changing anything. Many compounds below are not FDA-approved for human use; some are investigational or sold through unregulated channels where purity and dosing are not guaranteed.